Article
Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study.
BMC cancer - 12 Apr 2013
Hendlisz Alain, Golfinopoulos Vassilis, Deleporte Amelie, Paesmans Marianne, Mansy Hazem El, Garcia Camilo, Peeters Marc, Annemans Lieven, Vandeputte Caroline, Maetens Marion, Borbath Ivan, Dresse Damien, Houbiers Ghislain, Fried Michael, Awada Ahmad, Piccart Martine, Laethem Jean-Luc Van, Flamen Patrick
Abstract excerpt
BACKGROUND: Surgery is a curative treatment for patients with locally advanced colon cancer, but recurrences are frequent for those with stage III disease. FOLFOX adjuvant chemotherapy has been shown to improve recurrence-free survival and overall survival by more than 20% and is nowadays conside...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.